Author:
Miszczuk-Jamska Barbara,Merten Marc,Renaud Wanda,Guy-Crotte Odette,Figarella Catherine
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Miszczuk-Jamska B, Merten M, Guy-Crotte O, Amouric M, Clemente F, Schoumacher RA, Figarella C. Characterizationof trypsinogens 1 and 2 in two human pancreaticadenocarcinoma cell lines: CFPAC-1 and CAPAN-1.FEBSLett 1991; 294: 175–178.
2. Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA,Wallace RW, Tom Hon C, Kelly DR, Schmid SM, GelderFB, Rado TA, Frizzell RA. A cystic fibrosis pancreaticadenocarcinoma cell line.Proc Natl Acad Sci USA 1990; 87:4012–4016.
3. Koivunen E, Ristimaki A, Itkonen O, Osman S, Vuento M,Stenman UH. Tumor-associated trypsin participates incancer cell-mediated degradation of extracellular matrix.Cancer Res 1991; 51: 2107–2111.
4. Levrat JH, Palevody C, Daumas M, Ratovo G, Hollande E. Differentiation of the human pancreatic adenocarcinomacell line (CAPAN-1) in culture and co-culture with fibroblasts dome formation.Int J Cancer 1988; 42: 615–621.
5. Mc Intyre LJ, Kim YS. Effect of sodium butyrate anddimethyl sulfoxide on human pancreatic tumor cell lines.Eur J Cancer Oncol 1984; 20: 265–271.